Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b (Q73287232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

M Kruger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K H Böker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Zeidler

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M P Manns

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

935-939

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Hepatitis B and Immune-Complex Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

[Successful treatment of panarteritis nodosa with low-dose methotrexate therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Pharmacokinetics of vidarabine in the treatment of polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Treatment with interferon alpha and plasma exchange of periarteritis nodosa associated with acute viral hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

A cell culture assay for compounds which inhibit hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Safety of famciclovir in patients with herpes zoster and genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

Clinical relevance of mutations in the precore genome of the hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980263-2

7 January 2021

10.1016/S0168-8278(97)80263-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9126810%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference